Skip navigation

Canlyniadau chwilio am the

Yn dangos 286 i 300 o 2071 canlyniadau

The standards of proficiency for speech and language therapists

The standards of proficiency that speech and language therapists must meet in order to join, and remain on, the HCPC Register. 

Fitness To Practise Annual Report 2020-21

Our Fitness to practise report highlights key insights from the year, explains how we protect the public and shows how we help registrants meet our standards

Protected function - hearing aid dispensers

We regulate hearing aid dispensers on the basis of their professional title and also their protected function.

Breach of confidentiality

Case study: An occupational therapist's employer raised concerns with us after the registrant left a notepad containing confidential information, pertaining to a number of service users, at the home address of a service user.

Register summary

Statistical summary of the HCPC Register, including the number of registrants by profession, age profile and working location.

Reflecting on your practice and its emotional impact with Schwartz rounds

In 2019, we commissioned the University of Surrey to produce a film evidencing the process and benefits of Schwartz rounds.

Fitness to practice and the updated standards of proficiency

What employers need to know about our updated requirements for registrants to manage their mental and physcial health.

Launch of consultation for the standards of conduct, performance and ethics

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

We have revised our standards for prescribing

The Health and Care Professions Council has recently revised our standards for prescribing, following a public consultation. The revised standards took effect on 1 September 2019.

HCPC statement on guidance on health and character and suicidal ideation

Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)